Xagrid is a medicine which interferes with the development of platelets. It reduces the number of platelets produced by the bone marrow, which results in a decrease in the platelet count in the blood towards a more normal level. For this reason it...
Producer: Shire Pharmaceutical Contracts Limited
Therapeutic group: Antineoplastic agents